Viewing StudyNCT00129896



Ignite Creation Date: 2024-05-05 @ 11:45 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00129896
Status: COMPLETED
Last Update Posted: 2023-03-06
First Post: 2005-08-11

Brief Title: Neoadjuvant Chemotherapy With MyocetTaxotereHerceptin for HER2 Positive Breast Cancer Patients
Sponsor: Spanish Breast Cancer Research Group
Organization: Spanish Breast Cancer Research Group

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
Neoadjuvant treatment View
Her2neu positive breast cancer View